Shockwave Medical Inc (SWAV)
330.00
+1.01
(+0.31%)
USD |
NASDAQ |
Apr 26, 16:00
326.89
-3.11
(-0.94%)
After-Hours: 20:00
Shockwave Medical Enterprise Value: 12.04B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 12.04B |
| April 24, 2024 | 12.04B |
| April 23, 2024 | 12.03B |
| April 22, 2024 | 12.03B |
| April 19, 2024 | 12.04B |
| April 18, 2024 | 11.99B |
| April 17, 2024 | 11.99B |
| April 16, 2024 | 11.99B |
| April 15, 2024 | 11.97B |
| April 12, 2024 | 12.00B |
| April 11, 2024 | 12.01B |
| April 10, 2024 | 12.07B |
| April 09, 2024 | 11.98B |
| April 08, 2024 | 11.92B |
| April 05, 2024 | 11.95B |
| April 04, 2024 | 11.71B |
| April 03, 2024 | 11.74B |
| April 02, 2024 | 11.71B |
| April 01, 2024 | 11.73B |
| March 28, 2024 | 11.92B |
| March 27, 2024 | 11.81B |
| March 26, 2024 | 11.56B |
| March 25, 2024 | 10.48B |
| March 22, 2024 | 10.25B |
| March 21, 2024 | 10.41B |
| Date | Value |
|---|---|
| March 20, 2024 | 10.42B |
| March 19, 2024 | 10.18B |
| March 18, 2024 | 10.10B |
| March 15, 2024 | 9.988B |
| March 14, 2024 | 9.698B |
| March 13, 2024 | 9.815B |
| March 12, 2024 | 9.640B |
| March 11, 2024 | 9.380B |
| March 08, 2024 | 9.154B |
| March 07, 2024 | 9.319B |
| March 06, 2024 | 9.269B |
| March 05, 2024 | 9.158B |
| March 04, 2024 | 9.483B |
| March 01, 2024 | 9.592B |
| February 29, 2024 | 9.497B |
| February 28, 2024 | 9.560B |
| February 27, 2024 | 9.594B |
| February 26, 2024 | 9.460B |
| February 23, 2024 | 9.496B |
| February 22, 2024 | 9.858B |
| February 21, 2024 | 9.413B |
| February 20, 2024 | 9.329B |
| February 16, 2024 | 9.457B |
| February 15, 2024 | 8.483B |
| February 14, 2024 | 8.282B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
554.16M
Minimum
Mar 20 2020
12.07B
Maximum
Apr 10 2024
5.334B
Average
6.066B
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 116.03B |
| AtriCure Inc | 1.002B |
| Masimo Corp | 7.899B |
| Perspective Therapeutics Inc | 931.55M |
| Xtant Medical Holdings Inc | 133.46M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 44.30M |
| Revenue (Quarterly) | 202.98M |
| Total Expenses (Quarterly) | 159.70M |
| EPS Diluted (Quarterly) | 1.16 |
| Gross Profit Margin (Quarterly) | 87.53% |
| Profit Margin (Quarterly) | 21.83% |
| Earnings Yield | 1.17% |
| Operating Earnings Yield | 1.26% |
| Normalized Earnings Yield | 1.173 |